Moreover, it curtails VEGF-dependent angiogenic pathways and significantly reduces endoglin/pSmad1 levels, which inhibits tumor growth in human liver cancer (PMECs) and gastric cancer (SGC7901) cells and alleviates asthma symptoms [565–567]. Here, VEGFA is linked to neoplasm.